New data from the American Cancer Society reveals a historic survival milestone even as federal funding faces potential cuts.

Vague is a word frequently used to describe symptoms of ovarian cancer. However, if there are key and persistent signs that last more than two or three weeks, it likely would be wise to see a ...

It may be best not to go off-script when it comes to breast cancer. Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women ...

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

Co-occurring alterations in EGFR-mutant NSCLC are increasingly detected via broad NGS and may signal aggressive biology, prompting interest in escalation strategies that address concurrent drivers.

TORONTO — Michael Groves thought he had appendicitis.

A new report has laid bare how head and neck cancers have "persistently poor" survival rates in our region.

A new study shows that lowering protein intake could slow liver cancer in people with damaged livers. Researchers found that ...

Post-diagnosis weight gain over ~1.5 years is consistently associated with increased breast cancer–specific and all-cause mortality across meta-analyses. How GLP-1 weight-loss drugs fit after breast ...

A new American Cancer Society report shows colorectal cancer is rising in younger adults. Doctors urge people at average risk start screening at age 45.

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...